131 related articles for article (PubMed ID: 37751315)
1. Meta-analysis of sex and racial subgroup participation rates and differential treatment effects for trials in solid tumor malignancies leading to US Food and Drug Administration registration between 2010 and 2021.
Wilson BE; Nadler MB; Desnoyers A; Booth CM; Amir E
Cancer; 2024 Jan; 130(2):276-286. PubMed ID: 37751315
[TBL] [Abstract][Full Text] [Related]
2. Differential treatment effect between younger and older adults for new cancer therapies in solid tumors supporting US Food and Drug Administration approval between 2010 and 2021.
Wilson BE; Desnoyers A; Nadler MB; Amir E; Booth CM
Cancer; 2023 Oct; 129(20):3318-3325. PubMed ID: 37340792
[TBL] [Abstract][Full Text] [Related]
3. Participation of the elderly, women, and minorities in pivotal trials supporting 2011-2013 U.S. Food and Drug Administration approvals.
Downing NS; Shah ND; Neiman JH; Aminawung JA; Krumholz HM; Ross JS
Trials; 2016 Apr; 17():199. PubMed ID: 27079511
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Ten-Year Trends in Enrollment of Women and Minorities in Pivotal Trials Supporting Recent US Food and Drug Administration Approval of Novel Cardiometabolic Drugs.
Khan MS; Shahid I; Siddiqi TJ; Khan SU; Warraich HJ; Greene SJ; Butler J; Michos ED
J Am Heart Assoc; 2020 Jun; 9(11):e015594. PubMed ID: 32427023
[TBL] [Abstract][Full Text] [Related]
6. Racial/ethnic diversity in children's oncology clinical trials: ten years later.
Lund MJ; Eliason MT; Haight AE; Ward KC; Young JL; Pentz RD
Cancer; 2009 Aug; 115(16):3808-16. PubMed ID: 19484783
[TBL] [Abstract][Full Text] [Related]
7. Racial and Ethnic Disparities in Primary Open-Angle Glaucoma Clinical Trials: A Systematic Review and Meta-analysis.
Allison K; Patel DG; Greene L
JAMA Netw Open; 2021 May; 4(5):e218348. PubMed ID: 34003274
[TBL] [Abstract][Full Text] [Related]
8. Assessment of gender representation in clinical trials leading to FDA approval for oncology therapeutics between 2014 and 2019: A systematic review-based cohort study.
Dymanus KA; Butaney M; Magee DE; Hird AE; Luckenbaugh AN; Ma MW; Hall ME; Huelster HL; Laviana AA; Davis NB; Terris MK; Klaassen Z; Wallis CJD
Cancer; 2021 Sep; 127(17):3156-3162. PubMed ID: 34160824
[TBL] [Abstract][Full Text] [Related]
9. Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018.
Loree JM; Anand S; Dasari A; Unger JM; Gothwal A; Ellis LM; Varadhachary G; Kopetz S; Overman MJ; Raghav K
JAMA Oncol; 2019 Oct; 5(10):e191870. PubMed ID: 31415071
[TBL] [Abstract][Full Text] [Related]
10. Race and Ethnicity Reporting and Enrollment Disparities in Clinical Trials Leading to FDA Approvals for Breast Cancer Between 2010 and 2020.
Nguyen RH; Silva Y; Lu J; Chen Z; Gadi V
Clin Breast Cancer; 2023 Aug; 23(6):591-597. PubMed ID: 37296063
[TBL] [Abstract][Full Text] [Related]
11. Participation in cancer clinical trials: race-, sex-, and age-based disparities.
Murthy VH; Krumholz HM; Gross CP
JAMA; 2004 Jun; 291(22):2720-6. PubMed ID: 15187053
[TBL] [Abstract][Full Text] [Related]
12. Diversity in Orthopaedic Surgery Medical Device Clinical Trials: An Analysis of the Food and Drug Administration Safety and Innovation Act.
Issa TZ; Lambrechts MJ; Lin JS; Brush PL; Canseco JA; Hilibrand AS; Kepler CK; Schroeder GD; Vaccaro AR
J Am Acad Orthop Surg; 2023 Feb; 31(3):155-165. PubMed ID: 36525566
[TBL] [Abstract][Full Text] [Related]
13. Race reporting and diversity in US food and drug administration (FDA) registration trials for prostate cancer; 2006-2020.
Lythgoe MP; Krell J; Savage P; Prasad V
Prostate Cancer Prostatic Dis; 2021 Dec; 24(4):1208-1211. PubMed ID: 33859363
[TBL] [Abstract][Full Text] [Related]
14. Disparities in reporting and representation by sex, race, and ethnicity in endovascular aortic device trials.
Marcaccio CL; O'Donnell TFX; Dansey KD; Patel PB; Hughes K; Lo RC; Zettervall SL; Schermerhorn ML
J Vasc Surg; 2022 Nov; 76(5):1244-1252.e2. PubMed ID: 35623599
[TBL] [Abstract][Full Text] [Related]
15. Racial/Ethnic Disparities in Ophthalmology Clinical Trials Resulting in US Food and Drug Administration Drug Approvals From 2000 to 2020.
Berkowitz ST; Groth SL; Gangaputra S; Patel S
JAMA Ophthalmol; 2021 Jun; 139(6):629-637. PubMed ID: 33885724
[TBL] [Abstract][Full Text] [Related]
16. Is Our Science Representative? A Systematic Review of Racial and Ethnic Diversity in Orthopaedic Clinical Trials from 2000 to 2020.
Cwalina TB; Jella TK; Manyak GA; Kuo A; Kamath AF
Clin Orthop Relat Res; 2022 May; 480(5):848-858. PubMed ID: 34855650
[TBL] [Abstract][Full Text] [Related]
17. Underreporting and Underrepresentation of Race and Ethnicity in Head and Neck Cancer Trials, 2010-2020: A Systematic Review.
Sauer AB; Daher GS; Lohse CM; Glasgow AE; Habermann EB; Douse DM; Moore EJ; Ighodaro ET; Van Abel KM; Yin LX
JAMA Otolaryngol Head Neck Surg; 2022 Jul; 148(7):662-669. PubMed ID: 35653143
[TBL] [Abstract][Full Text] [Related]
18. Estimation of Study Time Reduction Using Surrogate End Points Rather Than Overall Survival in Oncology Clinical Trials.
Chen EY; Joshi SK; Tran A; Prasad V
JAMA Intern Med; 2019 May; 179(5):642-647. PubMed ID: 30933235
[TBL] [Abstract][Full Text] [Related]
19. Sex, Racial, and Ethnic Representation in COVID-19 Clinical Trials: A Systematic Review and Meta-analysis.
Xiao H; Vaidya R; Liu F; Chang X; Xia X; Unger JM
JAMA Intern Med; 2023 Jan; 183(1):50-60. PubMed ID: 36469312
[TBL] [Abstract][Full Text] [Related]
20. Disparities in the Inclusion of Racial and Ethnic Minority Groups and Older Adults in Prostate Cancer Clinical Trials: A Meta-analysis.
Riaz IB; Islam M; Ikram W; Naqvi SAA; Maqsood H; Saleem Y; Riaz A; Ravi P; Wang Z; Hussain SA; Warner JL; Odedina FT; Duma N; Singh P; Kehl KL; Kamran SC; Murad MH; Landman A; Van Allen E; Bryce AH
JAMA Oncol; 2023 Feb; 9(2):180-187. PubMed ID: 36416812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
